Form Type: 4

SEC EDGAR Link
Accession Number:0001562180-21-007530
Date:2021-12-02
Issuer: HEALTH CATALYST, INC. (HCAT)
Original Submission Date:

Reporting Person:

BURTON DANIEL D.
C/O HEALTH CATALYST, INC.
10897 SOUTH RIVER FRONT PARKWAY, #300 SOUTH JORDAN, UT 84095

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-12-02 F 4,410 d $41.95 241,871 direct
COMMON STOCK 2021-12-03 M 21,781 a $10.80 263,652 direct
COMMON STOCK 2021-12-03 M 14,431 a $15.84 278,083 direct
COMMON STOCK 2021-12-03 S 25,885 d $40.28 252,198 direct
COMMON STOCK 2021-12-03 S 10,127 d $41.47 242,071 direct
COMMON STOCK 2021-12-03 S 200 d $42.13 241,871 direct
COMMON STOCK 2021-12-06 M 11,126 a $10.80 252,997 direct
COMMON STOCK 2021-12-06 M 5,881 a $15.84 258,878 direct
COMMON STOCK 2021-12-06 S 21,972 d $40.06 236,906 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 15.84 2021-12-03 deemed execution date M 14,431 (d) 2029-02-05 common stock 14,431 $15.84 94,815 direct
STOCK OPTION (RIGHT TO BUY) 10.8 2021-12-03 deemed execution date M 21,781 (d) 2028-09-27 common stock 21,781 $10.80 184,399 direct
STOCK OPTION (RIGHT TO BUY) 15.84 2021-12-06 deemed execution date M 5,881 (d) 2029-02-05 common stock 5,881 $15.84 88,934 direct
STOCK OPTION (RIGHT TO BUY) 10.8 2021-12-06 deemed execution date M 11,126 (d) 2028-09-27 common stock 11,126 $10.80 173,273 direct
Footnotes
IDfootnote
f1 represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of issuer's restricted stock units. this sale is mandated by the issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
f2 represents a weighted average price reported by the broker. these shares were sold as part of a block trade in multiple transactions at prices ranging from $40.33 to $42.76, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote with regard to the block trade.
f3 the sale reported on this form 4 was made pursuant to a written trading plan adopted by the reporting person on march 4, 2021, in accordance with rule 10b5-1.
f4 represents the weighted average sale price of the shares sold ranging from $40.00 to $40.92 per share, inclusive.
f5 represents the weighted average sale price of the shares sold ranging from $41.09 to $41.79 per share, inclusive.
f6 represents the weighted average sale price of the shares sold ranging from $42.10 to $42.36 per share, inclusive.
f7 represents the weighted average sale price of the shares sold ranging from $40.00 to $40.35 per share, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) through (7).
f8 25% of the 299,748 shares underlying the option vested in an annual installment on february 5, 2020 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on february 5, 2023.
f9 25% of the 747,223 shares underlying the option vested in an annual installment on september 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on september 25, 2022.

Elevate your investments